This document discusses pharmacovigilance in India and proposes a new collaborative approach. It notes that India's large population could potentially provide a large adverse drug reaction database. It then outlines a proposed structure for a national pharmacovigilance program in India with zonal and regional centers coordinated by a National Pharmacovigilance Center run by the Drugs Controller General of India.